Nisha Hosadurg, MD
banner
nhosadurg.bsky.social
Nisha Hosadurg, MD
@nhosadurg.bsky.social
Cardiologist/Multimodal CV Imager @UVA | Training: @CardioUva ⬅️ @TuftsMedicalCtr| Interests in #yesCCT, #whyCMR, South Asian CVD, Womens CV Health
✨️Thrilled to see #UVA MS2 Ceylan Metin present our work from the #iPRIMEuva Coronary Atherosclerosis in Virginia (CAVA) cohort at #AHA25, showing that modest ⏫️ in 🩸A1C levels, even below prediabetic thresholds, predict high risk plaque on 🫀coronary CTA
November 9, 2025 at 3:24 AM
Reposted by Nisha Hosadurg, MD
TOP findings from #AHA25 found a liberal transfusion strategy did not reduce death or major ischemic outcome rates compared w/ a restrictive strategy in patients at ⬆️ risk of a cardiac event following major vascular or general surgery.

Get the details ➡️ https://bit.ly/4nMHXeD #CardioSky #MedSky
November 8, 2025 at 10:40 PM
Reposted by Nisha Hosadurg, MD
Studies like OCEAN from #AHA25 are reshaping strategies for managing #AFib, exploring topics like ongoing anticoagulation post-catheter ablation; optimal antithrombotic approaches after #cvPCI; and LAAC vs. medical therapy in high-risk patients.

More ➡️ https://bit.ly/47vGSTD #CardioSky #MedSky
November 8, 2025 at 9:30 PM
Reposted by Nisha Hosadurg, MD
🚨New at #AHA25 & in #JACC: In the MAPLE-HCM trial, those with obstructive #HCM treated with aficamten showed superior improvements vs. metoprolol in:

🫀HF symptoms
💪 Exercise capacity
⚡LVOT gradient
💬 Health status

Read more: tinyurl.com/yez2ybss

@accintouch.bsky.social @jaccjournals.bsky.social
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multi-Domain, Patient-Level Analysis of the MAPLE-HCM Trial:
www.jacc.org
November 8, 2025 at 8:52 PM
Reposted by Nisha Hosadurg, MD
#AHA25: ACC Vice President Roxana Mehran, MD, FACC, shares insights on groundbreaking cardiometabolic therapeutic trials, including highlights from the VESALIUS-CV study.

Get the full details here: https://bit.ly/4oBNohQ

#cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky
November 8, 2025 at 7:51 PM
👭🫀Engaging session on Unraveling the Mystery of 💫(A/I/MI) NOCAs at the #UVA #CVDinWomen symposium 🧵
November 1, 2025 at 6:59 PM
Managing #CVHealth in pregnancy at the CVD in Women Symposium at #UVA: @garimasharmamd.bsky.social, @agneskoczo.bsky.social and Dr. Chris Ennen highlight the role of,
🤰Comprehensive maternal risk stratification
🤝🩺Multidisciplinary cardio-obstetric teams
📈 APOs driving premature #CVD risk
November 1, 2025 at 5:45 PM
🔑✨️Powerful keynote session at the #CVD in Women Symposium at #UVA featuring heartfelt patient testimonials from inspiring women — reminding us of our WHY in advancing #womenshearthealth. 💖 @prodriguezmd.bsky.social @pamelamasonep.bsky.social @chriskramermd.bsky.social
November 1, 2025 at 2:33 PM
✨️Honored to represent #UVA and speak at the Indian Association of Charlottesville's #Diwali celebration 🎆 on #SouthAsian heart health awareness! Grateful for the opportunity to engage with the community on prevention and early action🫀💪🏽🪔 @prodriguezmd.bsky.social @chriskramermd.bsky.social
October 28, 2025 at 2:16 AM
Reposted by Nisha Hosadurg, MD
🆕 Career Advancement Opportunity for Women in Cardiology!

Connect with senior ACC leaders and secure national and international speaking opportunities with the 🆕 Using Her Voice Scholars Program.

Learn more and apply: https://bit.ly/46mzMQS

#ACCAcademic #CardioSky #MedSky
September 26, 2025 at 8:53 PM
✨️ A fabulous session on Imaging Across the Sex and Gender Spectrum at #SCCT2025 chaired by @prodriguezmd.bsky.social and @purviparwani.bsky.social with a 💫 stellar panel!

💠 ASK your 👭 patients about sex-specific risk factors like premature menopause, use of hormone supplementation.
July 19, 2025 at 9:22 PM
✨️ A fabulous session on Imaging Across the Sex and Gender Spectrum at #SCCT2025 chaired by @prodriguezmd.bsky.social and @purviparwani.bsky.social with a 💫 stellar panel!

💠 ASK your 👭 patients about sex-specific risk factors like premature menopause, use of hormone supplementation.
July 19, 2025 at 9:21 PM
🌟The #SCCT25 best abstract 🥇goes to Dr. Joel Lennell with the #WARRIOR serial imaging study of 👭 with suspected INOCA

✨️ OMT (ASA + statin + ACEi/ARB) results in ⬆️ lowering of non-calcified plaque volume on 2yr #yesCCT

@scct-heart.bsky.social
@drmarthagulati.bsky.social
@prodriguezmd.bsky.social
July 19, 2025 at 7:21 PM
💥 Congratulations to #SCCT2025 Young Investigator Awardee 🥇 Dr. Phyo Khaing for her amazing work on the SCOT-HEART 2: IMPACT study

✨️ #yesCCT guided primary prevention led to

✅️ 🎯 targeted recs for prevention.
✅️ ⬆️ patients accept preventive 💊.
✅️ Improved #CV risk factors.

@scct-heart.bsky.social
July 19, 2025 at 5:14 PM
Reposted by Nisha Hosadurg, MD
Follow #SCCT2025 social media ambassador Nisha Hosadurg @nhosadurg.bsky.social on Bluesky for updates & the latest trends in #yesCCT!
July 19, 2025 at 2:04 PM
💥 #yesCCT in asymptomatic patients? Dr. Todd Villines and Dr. Kelley Branch battle it out in a riveting 🔥 Great Debates in CCT session at #SCCT2025.

✨️The verdict?

✅️ Screening CCTA is relatively simple (think screening colonoscopies), 🪙 standard for plaque assessment & likely coming soon, but...
July 18, 2025 at 7:53 PM
✨️Highlights from the high yield #SCCT2025 Joint Session with @scainews.bsky.social on The Promise of CT guided PCI

✅️ Plaque anatomy, calcium density, plaque physiology helps guide stent size, location, need for lesion modification.

✅️ CCTA planning improves cath lab efficiency, radiation/contrast
July 18, 2025 at 4:43 PM
Reposted by Nisha Hosadurg, MD
We kicked off the @scainews.bsky.social - SCCT joint session with co-chair Jonathon Leipsic sharing key takeaways of #yesCCT guided PCI. Come join us in the general session room! #SCCT2025
July 18, 2025 at 2:32 PM
Reposted by Nisha Hosadurg, MD
Attendees learning about valve in valve cases during the Aortic and Mitral Valve - Procedural Planning Workshop #yesCCT #SCCT2025
July 17, 2025 at 3:38 PM
Reposted by Nisha Hosadurg, MD
#SCCT2025 CTA Academy covering image optimization, challenging cases (high HR, BMI, calcified plaque, stents) & coronaries — masses, pericardial, valvular, aortic & more.
July 17, 2025 at 3:44 PM
🌟Highly recommend! The pre conference workshops are always an excellent experience for interactive learning! @roosha.bsky.social #SCCT2025
We're wrapping up the Tricuspid, Pulmonic and LAAO Workshop. If you missed this or any of the specialty hands-on workshops in Montréal, make sure to save your spot at SCCT2026 and register early next year! ❤️ #SCCT2025 #yesCCT
July 17, 2025 at 9:54 PM
Reposted by Nisha Hosadurg, MD
We're wrapping up the Tricuspid, Pulmonic and LAAO Workshop. If you missed this or any of the specialty hands-on workshops in Montréal, make sure to save your spot at SCCT2026 and register early next year! ❤️ #SCCT2025 #yesCCT
July 17, 2025 at 8:19 PM
#SCCT2025 in Montréal is right around the corner! With a schedule full of learning and networking, I'm thrilled to be an official social media ambassador. Stay tuned! scct.org/page/SCCT2025 @scct-heart.bsky.social
July 16, 2025 at 11:15 AM
Reposted by Nisha Hosadurg, MD
Exciting news! SCCT & 6 societies just released expert consensus on cardiac CT for Prosthetic Heart Valve assessment! Get the latest on indications, protocols & reporting to enhance patient care. #CardioSky #YesCCT

scct.org/page/SCIDOC_...
July 2, 2025 at 2:35 PM
Thank you @scct-heart.bsky.social for this incredible honor! Humbled to have received this! @prodriguezmd.bsky.social @chriskramermd.bsky.social
Congratulations to @nhosadurg.bsky.social on being named the inaugural recipient of SCCT’s Chinnaiyan Catalyst Award for Women’s Cardiovascular Health Research! Her work on coronary CT and hypertensive disorders of pregnancy is breaking new ground. #SCCT2025 #CardioSky

scct.org/page/Chinnai...
June 11, 2025 at 1:27 AM